News Sentiment

MCRB sentiment intelligence

Seres Therapeutics Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 50 Balanced news tone 43 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 6.11 Week of 10 Jul 2026
Weighted tone 50/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Market update

84/100 classification confidence.

Company focus 35

directly relevant articles

Source quality 1

high-authority source matches

Trend context Trend inactive

-21.1% over one week, +7.2% over four weeks, trend inactive, and below fair value.

Latest direct headline Neutral

Form 4 Seres Therapeutics Inc For: 10 July By Investing.com

Market Reaction

Price moving ahead of tone

59/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Market update 84/100 classification
One-week reaction -21.1% Price reacting lower
Trend fit Trend inactive 7.2% over four weeks
Fair value -69.4% Below fair value
Value support

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 2
Neutral 39
Negative 2

Relevance

Why the article matched

Direct first
Direct company coverage 35
Industry context 8
Sector context 0

Sources

Coverage mix

Publishers
Stock Titan 18
GlobeNewswire 6
Market source 5
simplywall.st 3
Ad Hoc News 2
Investing.com Canada 1
MarketBeat 1
MT Newswires 1

Event Lens

What the news is about

Classified themes
Market update 28
Earnings 13
Balance sheet 2

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 31-43 of 43